Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global Narcolepsy Treatment Market is estimated at US$ 4.77 billion in 2022 and is projected to reach US$ 6.67 billion by 2028, growing at a CAGR of 5.7% during the forecast period (2022 to 2028).
Data Points | Market Insights |
---|---|
Market Value 2021 | US$ 4.50 billion |
Market Value 2022 | US$ 4.77 billion |
Market Value 2028 | US$ 6.67 billion |
CAGR 2022 to 2028 | 5.7% |
Market Share of Top 5 Countries | 54.4% |
Key Industry Players | ResMed Inc., Koninklijke Philips N.V., Merck & Co. Inc., Drive DeVilbiss Healthcare LLC, GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Pfizer Inc. |
Over the past few decades, the neurobiology of sleep has witnessed a substantial progress owing to the increasing development of animal models for understanding neurological functions of the brain and the complexities that may exist. This also includes the brain’s function in terms of sleep.
With the recent advent of the COVID-19 pandemic, there is a significant burden of respiratory distress caused by novel coronavirus, leading to respiratory failure and deaths associated with it, all across the globe. The burden has also led to a rise in sleep related disorders such as narcolepsy and cataplexy.
To promote awareness regarding sleep disorders and the availability of treatments associated with narcolepsy, various local, national and international institutes, councils and organizations have taken initiative approaches to raise informative facts on available options of narcolepsy treatment.
The rising awareness among patients due to the initiatives undertaken by such organizations are expected to prompt the understanding among people with regard to medications and treatment options available for narcolepsy.
Thus, the narcolepsy treatment market growth is provoked by the rising prevalence of sleep-related neurological disorders, increasing awareness regarding neurological disorders and the emergence of local pharmaceutical players.
The leading manufacturers operating in the global narcolepsy treatment market are focusing on launching new products and promoting their brands in order to gain maximum market share.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 5.74% |
H1, 2022 Projected | 5.75% |
H1, 2022 Outlook | 5.65% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 9 ↓ |
FMI presents a comparative analysis about the market growth rates and development prospects in the global narcolepsy treatment market. The market is subject to influence by rise in patient base, high product adoption rate in accordance with impact of macro and industry factors.
Key developments in this market include development of novel therapeutics, favourable government policies for start-ups and attractive reimbursement opportunities for patients.
According to FMI, the narcolepsy treatment market is expected to decrease by 09 Basis Point Share (BPS) in H1-2022 when compared with H1-2021. When comparing H1-2022 outlook and H1-2022 Projected growth, the difference of 10 BPS was observed.
Key factors involved in the decrease of BPS is attributed to the disruption caused by the advent of the COVID-19 pandemic, leading to delays by manufacturers or their partners in the initiation or enrolment of patients in clinical trials, difficulties launching or commercialising products, patient discontinuations in clinical trials, and other related activities, which could cause ongoing clinical trials to be delayed, reduce royalty revenues, increase development costs, and have a material adverse effect on manufacturers' financial condition, business, and operational results.
There are some plus points that stay ahead for the industry which include development of primary healthcare facilities and need for development of personalised medicine for orphan drugs.
The market value for narcolepsy treatment holds nearly 5.6% of the overall US$ 80.0 Bn sleep aids market in 2021.
The prevalence of disorders such as cataplexy, sleep paralysis and excessive daytime sleepiness (EDS) is increasing over the globe. There is an active association by many organizations worldwide for an intent to increase awareness regarding such neurological disorders which associate with sleep disturbances and respiratory distress.
Some active organizations include the Narcolepsy Network Inc., Wake up Narcolepsy, the American Sleep Association and the European Narcolepsy Network.
Furthermore, the use of modafinil for treatment of patients with narcolepsy has shown lesser side-effects, and has enhanced the growth of the narcolepsy treatment market. The growth of the narcolepsy treatment market is associated with the higher efficacy of modafinil than traditional stimulants for prevention of sleep disorders.
There have been major advances in the field of neurobiology on the basis of narcolepsy, but the management of narcolepsy disorder remains symptomatic in the current scenario. The management of excessive daytime sleepiness is done with psychostimulants such as armodafinil and amphetamines as a form of third-line therapy.
Narcolepsy treatment market has thus been an active area for drug development and advancement of wake-promoting agents over the past few years.
The global narcolepsy treatment market expanded at 5.1% CAGR over the past 8 years from 2013 to 2021. The market is expected to expand at a considerable growth rate over the next six years at a CAGR of close to 5.7%.
High disease burden of sleep related disorders over the globe, such as obstructive sleep apnea is continuously providing an opportunity for key players in the sleep aids market to explore novel product concentrations for the management of sleep associated disorders. Sleep apnea is transforming into an important cause of medical morbidity and mortality.
Increasing prevalence of sleep apnea and other sleep related disorders increases the demand for drugs and devices used for treating them. This is set to increase the global narcolepsy treatment market growth over the forecast period.
Moreover, there is a limited presence of manufacturers within the narcolepsy market. In countries, such as China and India, the primary healthcare facilities have a limited capacity due to a large population base. However, prevalence of sleep disorders, such as insomnia, narcolepsy and sleep apnea, is high and majority of the patients remain untreated due to limited resources.
Advanced healthcare technologies, such as sleep disorder diagnostic and therapeutic devices, will widen the scope for improvements in healthcare facilities in developing nations.
Additionally, narcolepsy treatment market also presents a lucrative stance in the development of personalized medicine for orphan diseases owing to the existing clinical, biological and genetic profiles of the disorder. This factor will aid in research and development processes for new drug development, and thus propel the growth of narcolepsy treatment market during the forecast period.
Lack of early diagnosis of sleep related problems can result into development of chronic conditions such as the risk of heart failure, high blood pressure, stroke, diabetes and obesity. Sleep disorders such as Obstructive Sleep Apnea (OSA) have a high global prevalence, however, there is lack of awareness regarding OSA and the symptoms are deemed inconsequential by many people suffering from it, thus impacting the quality of life of an individual, as well as their productivity.
The availability of drugs for the treatment of narcolepsy and insomnia is apparent in the market for use, however, side effects associated with the uptake of such stimulants has proven to be risk inducing, and is thus responsible for the hampered growth of narcolepsy treatment market.
Furthermore, the addictive nature of sleep inducing drugs prescribed for individuals with sleep disorders has raised concern regarding the administration of these drugs for a longer term. The side effects and the addictive nature of treatment drugs for narcolepsy pose as great threat to the growth of narcolepsy treatment market.
Dearth of skilled medical personnel for operating sleep devices, especially in developing economies has acted as a hindrance in the growth of narcolepsy treatment market across the globe.
The lack of accurate documentation for usage and licensing of sleeping pills, and improper standardization of equipment related with sleep devices such as CPAP and BiPAP are some additional factors responsible for slow growth of sleep aids market and thus narcolepsy treatment market worldwide.
The U.S. dominates the North American region with a total market share of nearly 91.4% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of this market is driven by advanced healthcare systems in the region and rising efforts by various organizations to spread awareness among the general population on the prevalence of narcolepsy and sleep associated disorders. One such example is the establishment of the American Sleep Association in the country.
Germany exhibited a market value share growth of nearly 22.4% in the Europe narcolepsy treatment market in 2021 and is expected to hold a market value share of 24.6% by the end of 2028. The growth is associated with the framework associated with new guidelines framed by the combined efforts of European Sleep Research Society (ESRS), European Academy of Neurology (EAN) and European Narcolepsy Network (EU-NN) for treatment of narcolepsy and associated sleep disorders in adults and children in the region.
In addition, favourable reimbursement policies for therapeutic products, strong clinical pipeline, and rising stress levels are the other factors anticipated to promote revenue growth.
China holds 28.2% share in the APAC narcolepsy treatment market in 2021, and is projected to grow at a lucrative rate of CAGR 9.8% during the forecast period. The growth of the narcolepsy treatment market in the country is attributed to the high prevalence of the disorder in the country and relatively less awareness among the general population in terms of the symptoms associated with narcolepsy.
The generative efforts to increase public awareness regarding sleep disorders including narcolepsy have led to the country being a lucrative segment for the growth of narcolepsy treatment market, given that there is an emergence of local pharmaceutical players in China.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Devices in narcolepsy treatment project a lucrative growth at a CAGR of 5.9% till the end of the forecast period, with the current market share of around 63.2% in 2021. This dominant market value is associated with the efficacy of devices such as CPAP and BiPAP machines in assistive breathing, thus providing relief from respiratory distress, and resulting in subsequent improvement in sleep and enhanced quality of life.
E-commerce holds current global narcolepsy treatment market value share of 19.6% in 2021, and is projected to achieve an estimated growth CAGR of 8.0% by the end of the forecast period. This growth is linked with the availability of devices for sleep apnea over electronic media, thus proving to be accessible within areas of low resource availability along with the lack of presence of local distributors.
The impact of the COVID-19 pandemic on the narcolepsy treatment market was highly restrictive and steeped negatively on the growth of the narcolepsy treatment market during the year 2020. The occurrence of patients suffering from acute respiratory distress syndrome witnessed an increase during the advent of the COVID-19 pandemic, owing to high prevalence of infection spread throughout the globe. This factor developed into severe shortage in number of available hospital beds and medical equipment.
The initiation of quarantine practices and lockdown impositions in several global regions posed an impact on the light-dark cycle among individuals, thus disrupting the circadian system. The eventual progression of exacerbated symptoms associated with existing narcolepsy surfaced through the disruption in the circadian rhythm.
The global trend also witnessed an increasing emergence in excessive daytime sleepiness, which led to an increase in the use of stimulants. With increased burden of disease, the increasing patient base for sleep related disorders and narcolepsy suffered a restrictive growth in terms of treatment options due to the manufacturing activities being focused on production of drugs and equipment needed for the treatment of COVID-19.
Subsequently, the relevance of impact of sleep associated disorders during the beginning of the COVID-19 pandemic has led to increased research on symptomatic treatment of narcolepsy, followed by the development of stimulants. This is expected to slowly increase the growth of the narcolepsy treatment market over the forecast period.
Key players in the narcolepsy treatment market focus on the acquisition of biopharmaceutical companies and possess a large pipeline for new molecular entities. Key players also collaborate and form alliance for product development and commercialization. Furthermore, major players focus on geographic expansion through inorganic growth strategy.
Similarly, recent developments related to companies manufacturing narcolepsy treatment market services and technologies have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2028 |
Historical Data Available for | 2013 to 2021 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, APAC, Middle East & Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, Poland, China, Japan, India, ASEAN, Australia, New Zealand, South Africa and GCC Countries |
Key Market Segments Covered | Product, Distribution Channel and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
By Product:
By Distribution Channel:
By Region:
The global narcolepsy treatment market is worth US$ 4.50 Bn in 2021.
The narcolepsy treatment market is expected to reach US$ 6.67 Bn by the end of 2028, with sales revenue expected to register 5.7% CAGR growth.
From 2013-2021, the market for narcolepsy treatment expanded at the rate of 5.1%.
The U.S., Germany, China, U.K. and Brazil are expected to drive demand for narcolepsy treatment market.
North America is one of the key segments for narcolepsy treatment market, with the U.S. expected to account over 89.9% of the North American market during the forecast period.
Demand for narcolepsy treatment in Europe is expected to register growth of 4.6% over the forecast period.
The U.S., China and Germany are key producers of narcolepsy treatment services.
China narcolepsy treatment market appears to uphold a revenue share of 28.2% in the APAC narcolepsy treatment market in 2021. Japan holds a revenue share of 20.7% in the APAC region in 2021, and is expected to grow at a CAGR of nearly 6.9%.
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Narcolepsy Treatment Market Opportunity Analysis 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. Market Background 4.1. Market Dynamics 4.1.1. Drivers 4.1.2. Restraints 4.1.3. Trends 4.2. Epidemiology Study 4.3. Pipeline Assessment 5. Global Economic Outlook 5.1. Gross Domestic Product by Region & Country, 2016 – 2021 5.2. Global Healthcare Market Indicators 6. North America Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 6.1. Introduction 6.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021 6.2.1. U.S. 6.2.2. Canada 6.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 6.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021 6.4.1. Narcolepsy Treatment Drugs 6.4.1.1. Modafinil 6.4.1.2. Sodium Oxybate 6.4.1.3. Armodafinil 6.4.1.4. Others 6.4.2. Devices 6.4.2.1. CPAP Devices 6.4.2.2. BiPAP Devices 6.4.2.3. APAP Devices 6.5. Market Size (US$ Mn) Forecast By Product, 2022-2028 6.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021 6.6.1. Hospital Pharmacies 6.6.2. Retail Pharmacies 6.6.3. e-commerce 6.6.4. Drug Stores 6.6.5. Others 6.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 6.8. Market Attractiveness Analysis 6.8.1. By Country 6.8.2. By Product 6.8.3. By Distribution Channel 7. Latin America Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 7.1. Introduction 7.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021 7.2.1. Brazil 7.2.2. Mexico 7.2.3. Rest of Latin America 7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 7.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021 7.4.1. Narcolepsy Treatment Drugs 7.4.1.1. Modafinil 7.4.1.2. Sodium Oxybate 7.4.1.3. Armodafinil 7.4.1.4. Others 7.4.2. Devices 7.4.2.1. CPAP Devices 7.4.2.2. BiPAP Devices 7.4.2.3. APAP Devices 7.5. Market Size (US$ Mn) Forecast By Product, 2022-2028 7.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021 7.6.1. Hospital Pharmacies 7.6.2. Retail Pharmacies 7.6.3. e-commerce 7.6.4. Drug Stores 7.6.5. Others 7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 7.8. Market Attractiveness Analysis 7.8.1. By Country 7.8.2. By Product 7.8.3. By Distribution Channel 8. Europe Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 8.1. Introduction 8.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021 8.2.1. Germany 8.2.2. U.K 8.2.3. France 8.2.4. Italy 8.2.5. Spain 8.2.6. Russia 8.2.7. Poland 8.2.8. Rest of Europe 8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 8.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021 8.4.1. Narcolepsy Treatment Drugs 8.4.1.1. Modafinil 8.4.1.2. Sodium Oxybate 8.4.1.3. Armodafinil 8.4.1.4. Others 8.4.2. Devices 8.4.2.1. CPAP Devices 8.4.2.2. BiPAP Devices 8.4.2.3. APAP Devices 8.5. Market Size (US$ Mn) Forecast By Product, 2022-2028 8.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021 8.6.1. Hospital Pharmacies 8.6.2. Retail Pharmacies 8.6.3. e-commerce 8.6.4. Drug Stores 8.6.5. Others 8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 8.8. Market Attractiveness Analysis 8.8.1. By Country 8.8.2. By Product 8.8.3. By Distribution Channel 9. Asia Pacific Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021 9.2.1. China 9.2.2. India 9.2.3. Japan 9.2.4. Australia and New Zealand 9.2.5. ASEAN 9.2.6. Rest of APAC 9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 9.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021 9.4.1. Narcolepsy Treatment Drugs 9.4.1.1. Modafinil 9.4.1.2. Sodium Oxybate 9.4.1.3. Armodafinil 9.4.1.4. Others 9.4.2. Devices 9.4.2.1. CPAP Devices 9.4.2.2. BiPAP Devices 9.4.2.3. APAP Devices 9.5. Market Size (US$ Mn) Forecast By Product, 2022-2028 9.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021 9.6.1. Hospital Pharmacies 9.6.2. Retail Pharmacies 9.6.3. e-commerce 9.6.4. Drug Stores 9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 9.8. Market Attractiveness Analysis 9.8.1. By Country 9.8.2. By Product 9.8.3. By Distribution Channel 10. Middle East and Africa Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021 10.2.1. GCC Countries 10.2.2. South Africa 10.2.3. Rest of Middle East and Africa 10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 10.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021 10.4.1. Narcolepsy Treatment Drugs 10.4.1.1. Modafinil 10.4.1.2. Sodium Oxybate 10.4.1.3. Armodafinil 10.4.1.4. Others 10.4.2. Devices 10.4.2.1. CPAP Devices 10.4.2.2. BiPAP Devices 10.4.2.3. APAP Devices 10.5. Market Size (US$ Mn) Forecast By Product, 2022-2028 10.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021 10.6.1. Hospital Pharmacies 10.6.2. Retail Pharmacies 10.6.3. e-commerce 10.6.4. Drug Stores 10.6.5. Others 10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 10.8. Market Attractiveness Analysis 10.8.1. By Country 10.8.2. By Product 10.8.3. By Distribution Channel 11. Forecast Factors: Relevance and Impact 12. Forecast Assumptions 13. Competition Analysis 13.1. Competition Dashboard 13.2. Competitors Deep Dive 13.2.1. Merck & Co. Inc. 13.2.2. Pfizer Inc. 13.2.3. ResMed Inc. 13.2.4. GlaxoSmithKline Plc. 13.2.5. Fisher & Paykel Healthcare Limited 13.2.6. Drive DeVilbiss Healthcare LLC 13.2.7. Koninklijke Philips N.V. 14. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 by Region 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Analysis by Region 14.2.1. North America 14.2.2. Latin America 14.2.3. Europe 14.2.4. Asia Pacific 14.2.5. Middle East and Africa 14.3. Market Size (US$ Mn) Forecast By Region 14.4. Market Attractiveness Analysis by Region 15. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Product 15.1. Introduction/Key Finding 15.2. Historical Market Size (US$ Mn) Analysis by Product, 2013-2021 15.2.1. Narcolepsy Treatment Drugs 15.2.1.1. Modafinil 15.2.1.2. Sodium Oxybate 15.2.1.3. Armodafinil 15.2.1.4. Others 15.2.2. Devices 15.2.2.1. CPAP Devices 15.2.2.2. BiPAP Devices 15.2.2.3. APAP Devices 15.2.3. Market Size (US$ Mn) Forecast By Product, 2022-2028 15.2.4. Market Attractiveness Analysis by Product 16. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Distribution Channel 16.1. Introduction/Key Finding 16.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2013-2021 16.2.1. Hospital Pharmacies 16.2.2. Retail Pharmacies 16.2.3. e-commerce 16.2.4. Drug Stores 16.2.5. Others 16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 16.4. Market Attractiveness Analysis by Distribution Channel 17. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 17.1. Market Value Share Analysis by All Segment 17.2. Y-o-Y Growth Analysis by All Segment 17.3. Absolute $ Opportunity 18. Assumptions and Acronyms Used 19. Research Methodology
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 Table 03: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 04: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 05: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 06: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 07: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 08: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 09: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 10: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 11: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 12: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 13: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 14: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 15: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 16: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 17: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 18: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region Table 19: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 20: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Figure 1: Narcolepsy Treatment Market Value Share by Region (2022) Figure 2: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005–2010 Figure 3: Global Healthcare Expenditure in US$ Tn (2013–2021) Figure 4: North America Narcolepsy Treatment Market Value Share (2021A), By Country Figure 5: North America Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel Figure 6: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 7: North America Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 8: North America Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 9: U.S. Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 10: U.S. Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 11: Canada Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 12: Canada Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 13: North America Narcolepsy Treatment Market Attractiveness Analysis, By Country Figure 14: North America Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 15: North America Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 16: Latin America Narcolepsy Treatment Market Value Share (2021A), By Country Figure 17: Latin America Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel Figure 18: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 19: Latin America Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 20: Latin America Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 21: Brazil Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 22: Brazil Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 23: Mexico Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 24: Mexico Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 25: Rest of Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 26: Rest of Latin America Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 27: Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Country Figure 28: Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 29: Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 30: Europe Narcolepsy Treatment Market Value Share (2021A), By Country Figure 31: Europe Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel Figure 32: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 33: Europe Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 34: Europe Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 35: Germany Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 36: Germany Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 37: U.K. Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 38: U.K. Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 39: France Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 40: France Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 41: Italy Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 42: Italy Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 43: Spain Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 44: Spain Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 45: Russia Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 46: Russia Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 47: Poland Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 48: Poland Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 49: Rest of Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 50: Rest of Europe Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 51: Europe Narcolepsy Treatment Market Attractiveness Analysis, By Country Figure 52: Europe Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 53: Europe Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 54: Asia Pacific Narcolepsy Treatment Market Value Share (2021A), By Country Figure 55: Asia Pacific Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel Figure 56: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 57: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 58: Asia Pacific Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 59: China Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 60: China Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 61: India Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 62: India Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 63: Japan Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 64: Japan Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 65: Australia & New Zealand Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 66: Australia & New Zealand Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 67: ASEAN Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 68: ASEAN Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 69: Rest of Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 70: Rest of Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 71: Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Country Figure 72: Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 73: Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 74: Middle East & Africa Narcolepsy Treatment Market Value Share (2021A), By Country Figure 75: Middle East & Africa Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel Figure 76: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 77: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 78: Middle East & Africa Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 79: GCC Countries Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 80: GCC Countries Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 81: South Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 82: South Africa Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 83: Rest of MEA Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021 Figure 84: Rest of MEA Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028 Figure 85: Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Country Figure 86: Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 87: Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 88: Global Narcolepsy Treatment Market Attractiveness Analysis, By Region Figure 89: Global Narcolepsy Treatment Market Value Share Analysis, By Region, 2021 & 2028 Figure 90: Global Narcolepsy Treatment Market Attractiveness Analysis, By Product Figure 91: Global Narcolepsy Treatment Market Value Share Analysis, By Product, 2021 & 2028 Figure 92: Global Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel Figure 93: Global Narcolepsy Treatment Market Value Share Analysis, By Distribution Channel, 2021 & 2028 Figure 94: Global Narcolepsy Treatment Market Size and Y-o-Y, 2013 - 2021 Figure 95: Global Narcolepsy Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Recommendations
Explore Healthcare Insights
View Reports